Adverum Biotechnologies, Inc. (ADVM)
Dec 9, 2025 - ADVM was delisted (reason: acquired by LLY)
4.360
+0.100 (2.35%)
Inactive ยท Last trade price on Dec 8, 2025
Adverum Biotechnologies Employees
Adverum Biotechnologies had 155 employees as of December 31, 2024. The number of employees increased by 34 or 28.10% compared to the previous year.
Employees
155
Change (1Y)
34
Growth (1Y)
28.10%
Revenue / Employee
n/a
Profits / Employee
-$1,192,213
Market Cap
96.26M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2024 | 155 | 34 | 28.10% |
| Dec 31, 2023 | 121 | -2 | -1.63% |
| Dec 31, 2022 | 123 | -65 | -34.57% |
| Dec 31, 2021 | 188 | 21 | 12.57% |
| Dec 31, 2020 | 167 | 53 | 46.49% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
ADVM News
- 11 months ago - Lilly and Adverum announce expiration and completion of Adverum tender offer and acquisition - PRNewsWire
- 11 months ago - Adverum Reminds Stockholders to Tender their Shares into the Offer by Lilly - GlobeNewsWire
- 1 year ago - Adverum Biotechnologies Investor Alert By The Former Attorney General Of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Adverum Biotechnologies, Inc. - ADVM - Business Wire
- 1 year ago - Eli Lilly to buy gene therapy developer Adverum in about $262 million deal - Reuters
- 1 year ago - Lilly to Acquire Adverum Biotechnologies - PRNewsWire
- 1 year ago - Adverum Biotechnologies Announces Completion of Screening for Pivotal Phase 3 ARTEMIS Trial of Ixo-vec for Wet Age-Related Macular Degeneration - GlobeNewsWire
- 1 year ago - Adverum Biotechnologies Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 1 year ago - Adverum Biotechnologies Reports Second Quarter 2025 Financial Results and Provides Pipeline Highlights - GlobeNewsWire